A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children
Status:
Completed
Trial end date:
2001-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of a soft-gel capsule
formulation of saquinavir (SQV-SGC), a protease inhibitor, when given in combination with
other anti-HIV drugs.
SQV-SGC has been tested in adults for the treatment of HIV infection, but more information is
still needed about SQV-SGC in children. Recent studies suggest that this soft-gel capsule
form may be safer and more effective than other protease inhibitors.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)